BioNTech plans modular vaccine factories in Africa

BioNTech has been criticized by some campaign groups for refusing to suspend its vaccine patents and let rivals manufacture the shots as part of an effort to make them more widely available, especially in poor countries.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil